Developer docs
API playgroundTry for free, no card

Search company profiles

Henry Meds

Full company profile

uuid0006676

Namestring
Henry Meds
Legal namestring
Adonis Health, Inc.
Websiteurl
henrymeds.com
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Henry Meds, operated by Adonis Health, Inc. (a Delaware corporation), is a direct-to-consumer telehealth platform founded in 2022 that connects adult patients with licensed healthcare providers for remote consultation and prescription services. The platform is organized around four clinical verticals: weight management (compounded GLP-1 medications including injectable and oral semaglutide, oral tirzepatide, liraglutide, and phentermine, plus a Microdose program), women's hormone replacement therapy (estrogen and progesterone in tablets, patches, and creams, with optional testosterone cream), men's testosterone replacement therapy (injectable testosterone cypionate, topical cream, enclomiphene, or oral KYZATREX), and erectile dysfunction treatment (oral PDE-5 inhibitors and intracavernous Trimix/Bimix/Quadmix injections). The core technology stack is a telehealth platform that handles online medical intake, provider matching, video consultation, secure messaging, and prescription routing to fulfillment partners.

The business model is a self-pay, subscription-based cash-pay model with no insurance participation. Plans bundle provider visits, medication, supplies, and shipping at monthly prices ranging from $50 (oral ED) to $297 (injectable GLP-1), with 6-month and 12-month prepay options carrying meaningful discounts. A $30 non-refundable medical consultation fee is charged when a prescription is issued. Medications are compounded and dispensed through partnerships with licensed U.S. 503A and 503B compounding pharmacies and shipped directly to patients, while laboratory testing is coordinated through Quest Diagnostics with hybrid at-home collection via Tasso+ devices. Marketing is asset-light and DTC, relying on Trustpilot reviews, referral and affiliate programs with tracked codes, and content marketing. The company operates from Las Vegas, Nevada with an additional office in Katowice, Poland, and is supported by early-stage capital from Heron Rock Fund (2022). Compliance posture includes HIPAA, CCPA, and LegitScript certification.

Short descriptiontext

Henry Meds is a direct-to-consumer telehealth platform connecting adults with licensed providers for weight management (compounded GLP-1s), women's HRT, men's TRT, and ED treatment via subscription cash-pay plans with home-delivered compounded medications.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersDover, United States
HQ citystring
Dover
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
telehealth services, weight management treatment, hormone replacement therapy, compounded medications, direct-to-consumer healthcare
Industry2 codes
PRIMARYHLALAIAA
DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription)
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLALAAAA
Primary Care & General Medicine Virtual Care
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms
NAICS code1 code
  • Offices of Physicians (except Mental Health Specialists)621111
SIC code2 codes
  • Services-Health Services8000
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Telehealth Healthcare Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Subscription Plans
TypeSubscription Recurring
Description

Monthly subscription plans bundling provider consultations, prescribed medications, supplies, and shipping. Plans range from $50/month (oral ED) to $297/month (semaglutide injections). Multi-month plans offer discounts (6-month and 12-month options). A $30 non-refundable medical consultation fee is charged when a prescription is issued.

henrymeds.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain
Pricing details10 tiers
1Liraglutide Daily Injections - $179/month
ModelSubscriptionBilling cadenceMonthly
Notes

$179/month includes up to 90mg of compounded liraglutide every 60 days with injection kit. $1,074 for 6 months ($894 paid in full), $2,148 for 12 months ($1,428 paid in full).

henrymeds.com
2Semaglutide Weekly/Biweekly Injections - $297/month
ModelSubscriptionBilling cadenceMonthly
Notes

$297/month includes up to 10mg every 70 days or 12.5mg every 90 days with injection kit. $1,782 for 6 months ($1,482 paid in full), $3,564 for 12 months ($2,364 paid in full).

henrymeds.com
3Phentermine Weight Management - $149/month
ModelSubscriptionBilling cadenceMonthly
Notes

$149/month includes up to 30 capsules or tablets of 37.5mg phentermine (not available in CA for compounded SR version).

henrymeds.com
4Oral Semaglutide Tablets - $249/month
ModelSubscriptionBilling cadenceMonthly
Notes

$249/month includes up to 180mg of compounded orally dissolving semaglutide tablets every 60 days. $1,074 for 6 months ($1,014 paid in full), $2,148 for 12 months ($1,788 paid in full).

henrymeds.com
5Tirzepatide Oral Tablets - $1,047/3-months
ModelSubscriptionBilling cadenceMulti-year contract
Notes

$1,047 for 3-month supply ($891 if paid in full) includes up to 6mg compounded orally dissolving tirzepatide tablets taken daily.

henrymeds.com
6Sublingual Semaglutide (Drops/Tablets) - $179/month
ModelSubscriptionBilling cadenceMonthly
Notes

$179/month includes up to 60mg of compounded sublingual semaglutide (drops) or orally dissolving tablets every 60 days.

henrymeds.com
7Testosterone Replacement Therapy - $129/month
ModelSubscriptionBilling cadenceMonthly
Notes

$129/month includes testosterone cypionate injection (up to 1,000mg/28 days), testosterone cream (up to 18,000mg/90 days), or enclomiphene capsules, plus anastrozole and labs.

henrymeds.com
8Women's HRT - $149/month
ModelSubscriptionBilling cadenceMonthly
Notes

$149/month includes estrogen options (Estradiol tablets, patches, or Bi-Est cream) and progesterone options (tablets or cream). $100 additional for Testosterone Cream.

henrymeds.com
9ED Oral Medications - $50/month
ModelSubscriptionBilling cadenceMonthly
Notes

$50/month for oral ED medications including sildenafil (20mg, 60mg, 100mg tablets), tadalafil (3mg, 10mg, 20mg), or dissolving combination tablets.

henrymeds.com
10ED Injections (Bimix/Trimix/Quadmix) - $149/month
ModelSubscriptionBilling cadenceMonthly
Notes

$149/month for ICP injections including Bimix (papaverine + phentolamine), Trimix (adds alprostadil), or Quadmix (adds atropine), with needles, syringes, and alcohol swabs.

henrymeds.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Henry Meds is a direct-to-consumer telehealth platform that connects patients with licensed healthcare providers for personalized treatment of chronic conditions, including weight management (GLP-1 medications), hormone replacement therapy (women's HRT and men's TRT), and erectile dysfunction therapy. Prescribed compounded medications are fulfilled by licensed U.S. compounding pharmacies and shipped directly to patients' homes on a self-pay, all-inclusive monthly subscription basis without requiring insurance.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Patients lost approximately 18% of body weight in a year using injectable semaglutide through Henry Meds
Product overview1 text field

Henry Meds is a telehealth platform offering personalized, affordable healthcare across four core verticals: Weight Management, Women's Hormone Replacement Therapy (HRT), Testosterone Replacement Therapy (TRT), and Erectile Dysfunction (ED) treatment. The platform operates as a unified service connecting patients with licensed healthcare providers through telehealth consultations, with prescribed medications fulfilled by licensed compounding pharmacies and shipped directly to patients. The Weight Management program includes multiple GLP-1 medication options (semaglutide, tirzepatide, liraglutide) in both injectable and oral forms, plus phentermine. The HRT and TRT programs provide hormone therapies with various delivery methods. The ED program offers both oral PDE-5 inhibitors and injectable ICP medications (Bimix, Trimix, Quadmix). All services include provider visits, medication, supplies, and ongoing care in subscription pricing with no insurance required.

Product and service10 records
1GLP-1 Weight Management Program
CategoryWeight Management Program
Description

Monthly subscription program pairing patients with licensed providers for personalized weight management treatment using compounded GLP-1 medications dispensed by U.S. compounding pharmacies and shipped to patients' homes.

2Compounded Semaglutide Injection
CategoryCompounded GLP-1 Medication
Description

Compounded injectable semaglutide (GLP-1 agonist) dispensed for weight management patients enrolled in the Henry Meds subscription program.

3Compounded Semaglutide Oral Dissolvable Tablets
CategoryCompounded GLP-1 Medication
Description

Oral dissolvable tablet form of compounded semaglutide offered as an alternative for weight management patients who prefer oral delivery.

4Compounded Tirzepatide Oral Dissolvable Tablets
CategoryCompounded GLP-1/GIP Medication
Description

Compounded tirzepatide in oral dissolvable tablet form dispensed for weight management patients enrolled in the Henry Meds subscription program.

5Compounded Liraglutide Injection
CategoryCompounded GLP-1 Medication
Description

Compounded injectable liraglutide (GLP-1 agonist) dispensed for weight management patients enrolled in the Henry Meds subscription program.

6Phentermine Weight Management Program
CategoryWeight Management Program
Description

Weight management program using oral phentermine prescriptions for eligible patients seeking an alternative to GLP-1 medications.

7Women's Hormone Replacement Therapy (HRT) Program
CategoryHormone Replacement Therapy
Description

Monthly subscription program connecting women with licensed providers for personalized hormone replacement therapy, with compounded medications shipped to the patient's home.

8Men's Testosterone Replacement Therapy (TRT) Program
CategoryHormone Replacement Therapy
Description

Monthly subscription program pairing male patients with licensed providers for testosterone replacement therapy, including compounded testosterone medications delivered to the home.

9Erectile Dysfunction (ED) Treatment Program
CategoryMen's Health Treatment
Description

Monthly subscription program providing telehealth consultations and compounded ED medications to male patients seeking discreet treatment of erectile dysfunction.

10ICP Injections
CategoryMen's Health Treatment
Description

Intracavernosal Pharmacotherapy injections offered as a treatment option for erectile dysfunction patients.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Licensed U.S. Compounding Pharmacies (503A/503B)
Strategic tierCoreTypeTechnology or Integration
Description

Henry Meds partners with licensed U.S. compounding pharmacies operating under 503A and 503B regulations to prepare customized medications tailored to individual patient needs. These pharmacies dispense medications directly to patients as prescribed by Henry Meds providers.

henrymeds.com
Strategic tierCoreTypeTechnology or Integration
Description

Quest Diagnostics provides laboratory testing services for Henry Meds patients, including at-home collection options via Quest facilities or through hybrid solutions like Tasso+ self-collection devices.

Strategic tierMinorTypeOthers
Description

AAA administers arbitration proceedings for dispute resolution under the consumer arbitration rules and consumer due process protocol, as specified in the terms of service.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Ro
TypeDirect peer
Description

DTC telehealth company operating in weight management (including compounded GLP-1s through Ro Pharmacy), men's health, and women's health on a cash-pay subscription model. Direct overlap with Henry Meds' core verticals and pharmacy-fulfillment approach.

2Noom Med
TypeDirect peer
Description

Subsidiary of Noom offering clinician-supervised GLP-1 weight management on a cash-pay monthly subscription. Directly overlaps with Henry Meds' GLP-1 weight management program and shares the cash-pay chronic-condition positioning.

TypeEmerging player
Description

Telehealth primary care and weight management platform offering GLP-1 treatment via insurance and cash-pay options. Adjacent competitor in Henry Meds' weight management vertical with broader primary care scope.

TypeDirect peer
Description

Subscription-based telehealth platform offering weight management (including compounded semaglutide via subsidiary), men's hormone therapy, women's HRT, and ED treatment. Operates on a similar cash-pay subscription model with vertically integrated pharmacy.

TypeOthers
Description

National clinical laboratory partner of Henry Meds providing lab testing services (including via Tasso at-home collection). Enabler in Henry Meds' HRT/TRT service delivery rather than a direct competitor.

TypeEmerging player
Description

Specialty telehealth clinic focused on testosterone replacement therapy, men's hormone optimization, and weight management with cash-pay subscription pricing. Directly overlaps with Henry Meds' TRT and weight management verticals, smaller scale.

TypeDirect peer
Description

DTC telehealth subscription service for oral erectile dysfunction medications (sildenafil/tadalafil) on a cash-pay monthly model. Directly comparable to Henry Meds' ED oral offering on price, channel, and customer profile.

TypeDirect peer
Description

DTC telehealth marketplace offering weight loss (including GLP-1 programs), men's and women's health, and primary care on cash-pay pricing. Competes with Henry Meds on the cash-pay chronic-condition patient with similar self-pay positioning.

TypeDirect peer
Description

DTC telehealth platform offering ED, hair loss, and weight management on cash-pay subscription pricing. Directly comparable subscription model and cash-pay chronic-condition positioning to Henry Meds.

TypeDirect peer
Description

Publicly traded DTC telehealth platform offering weight loss (GLP-1s), men's health (TRT, ED), women's health (HRT), and hair/skin care on a subscription cash-pay model. Closest direct competitor to Henry Meds across all four product verticals with materially larger scale and brand reach.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Henry Meds

Telehealth Healthcare Serviceshenrymeds.com

Henry Meds is a direct-to-consumer telehealth platform connecting adults with licensed providers for weight management (compounded GLP-1s), women's HRT, men's TRT, and ED treatment via subscription cash-pay plans with home-delivered compounded medications.

What Henry Meds does

Henry Meds, operated by Adonis Health, Inc. (a Delaware corporation), is a direct-to-consumer telehealth platform founded in 2022 that connects adult patients with licensed healthcare providers for remote consultation and prescription services. The platform is organized around four clinical verticals: weight management (compounded GLP-1 medications including injectable and oral semaglutide, oral tirzepatide, liraglutide, and phentermine, plus a Microdose program), women's hormone replacement therapy (estrogen and progesterone in tablets, patches, and creams, with optional testosterone cream), men's testosterone replacement therapy (injectable testosterone cypionate, topical cream, enclomiphene, or oral KYZATREX), and erectile dysfunction treatment (oral PDE-5 inhibitors and intracavernous Trimix/Bimix/Quadmix injections). The core technology stack is a telehealth platform that handles online medical intake, provider matching, video consultation, secure messaging, and prescription routing to fulfillment partners.

The business model is a self-pay, subscription-based cash-pay model with no insurance participation. Plans bundle provider visits, medication, supplies, and shipping at monthly prices ranging from $50 (oral ED) to $297 (injectable GLP-1), with 6-month and 12-month prepay options carrying meaningful discounts. A $30 non-refundable medical consultation fee is charged when a prescription is issued. Medications are compounded and dispensed through partnerships with licensed U.S. 503A and 503B compounding pharmacies and shipped directly to patients, while laboratory testing is coordinated through Quest Diagnostics with hybrid at-home collection via Tasso+ devices. Marketing is asset-light and DTC, relying on Trustpilot reviews, referral and affiliate programs with tracked codes, and content marketing. The company operates from Las Vegas, Nevada with an additional office in Katowice, Poland, and is supported by early-stage capital from Heron Rock Fund (2022). Compliance posture includes HIPAA, CCPA, and LegitScript certification.

Henry Meds firmographics

Firmographics
Name
Henry Meds
Legal name
Adonis Health, Inc.
Website
https://henrymeds.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
101–250 employees
Short description
Henry Meds is a direct-to-consumer telehealth platform connecting adults with licensed providers for weight management (compounded GLP-1s), women's HRT, men's TRT, and ED treatment via subscription cash-pay plans with home-delivered compounded medications.
Ownership category
akta.pro rank

Henry Meds industry classification

Industry
Product category
Telehealth Healthcare Services
NAICS
Offices of Physicians (except Mental Health Specialists) (621111)
SIC
Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro industry
PRIMARYHLALAIAA
DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription)
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLALAAAA
Primary Care & General Medicine Virtual Care
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms

Keywords

  • Telehealth services
  • Weight management treatment
  • Hormone replacement therapy
  • Compounded medications
  • Direct-to-consumer healthcare

Where Henry Meds is headquartered

Location

Headquarters

HQ city
Dover
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Henry Meds business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

  1. Subscription Plans: Monthly subscription plans bundling provider consultations, prescribed medications, supplies, and shipping. Plans range from $50/month (oral ED) to $297/month (semaglutide injections). Multi-month plans offer discounts (6-month and 12-month options). A $30 non-refundable medical consultation fee is charged when a prescription is issued.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyLiraglutide Daily Injections - $179/month
SubscriptionMonthlySemaglutide Weekly/Biweekly Injections - $297/month
SubscriptionMonthlyPhentermine Weight Management - $149/month
SubscriptionMonthlyOral Semaglutide Tablets - $249/month
SubscriptionMulti-year contractTirzepatide Oral Tablets - $1,047/3-months
SubscriptionMonthlySublingual Semaglutide (Drops/Tablets) - $179/month
SubscriptionMonthlyTestosterone Replacement Therapy - $129/month
SubscriptionMonthlyWomen's HRT - $149/month
SubscriptionMonthlyED Oral Medications - $50/month
SubscriptionMonthlyED Injections (Bimix/Trimix/Quadmix) - $149/month

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Henry Meds product offering

Product offering

Core offering

Henry Meds is a direct-to-consumer telehealth platform that connects patients with licensed healthcare providers for personalized treatment of chronic conditions, including weight management (GLP-1 medications), hormone replacement therapy (women's HRT and men's TRT), and erectile dysfunction therapy. Prescribed compounded medications are fulfilled by licensed U.S. compounding pharmacies and shipped directly to patients' homes on a self-pay, all-inclusive monthly subscription basis without requiring insurance.

Product overview

Henry Meds is a telehealth platform offering personalized, affordable healthcare across four core verticals: Weight Management, Women's Hormone Replacement Therapy (HRT), Testosterone Replacement Therapy (TRT), and Erectile Dysfunction (ED) treatment. The platform operates as a unified service connecting patients with licensed healthcare providers through telehealth consultations, with prescribed medications fulfilled by licensed compounding pharmacies and shipped directly to patients. The Weight Management program includes multiple GLP-1 medication options (semaglutide, tirzepatide, liraglutide) in both injectable and oral forms, plus phentermine. The HRT and TRT programs provide hormone therapies with various delivery methods. The ED program offers both oral PDE-5 inhibitors and injectable ICP medications (Bimix, Trimix, Quadmix). All services include provider visits, medication, supplies, and ongoing care in subscription pricing with no insurance required.

Differentiator

Problem solved

Functional benefit

Products and services

  • GLP-1 Weight Management Program Monthly subscription program pairing patients with licensed providers for personalized weight management treatment using compounded GLP-1 medications dispensed by U.S. compounding pharmacies and shipped to patients' homes.
  • Compounded Semaglutide Injection Compounded injectable semaglutide (GLP-1 agonist) dispensed for weight management patients enrolled in the Henry Meds subscription program.
  • Compounded Semaglutide Oral Dissolvable Tablets Oral dissolvable tablet form of compounded semaglutide offered as an alternative for weight management patients who prefer oral delivery.
  • Compounded Tirzepatide Oral Dissolvable Tablets Compounded tirzepatide in oral dissolvable tablet form dispensed for weight management patients enrolled in the Henry Meds subscription program.
  • Compounded Liraglutide Injection Compounded injectable liraglutide (GLP-1 agonist) dispensed for weight management patients enrolled in the Henry Meds subscription program.
  • Phentermine Weight Management Program Weight management program using oral phentermine prescriptions for eligible patients seeking an alternative to GLP-1 medications.
  • Women's Hormone Replacement Therapy (HRT) Program Monthly subscription program connecting women with licensed providers for personalized hormone replacement therapy, with compounded medications shipped to the patient's home.
  • Men's Testosterone Replacement Therapy (TRT) Program Monthly subscription program pairing male patients with licensed providers for testosterone replacement therapy, including compounded testosterone medications delivered to the home.
  • Erectile Dysfunction (ED) Treatment Program Monthly subscription program providing telehealth consultations and compounded ED medications to male patients seeking discreet treatment of erectile dysfunction.
  • ICP Injections Intracavernosal Pharmacotherapy injections offered as a treatment option for erectile dysfunction patients.

Quantifiable outcome

  • Patients lost approximately 18% of body weight in a year using injectable semaglutide through Henry Meds

Companies that use Henry Meds

Customer profile

Segments4 records

Ideal customer profiles1 record

Henry Meds technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

Feature3 records

Henry Meds partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Licensed U.S. Compounding Pharmacies (503A/503B)coreTechnology or IntegrationHenry Meds partners with licensed U.S. compounding pharmacies operating under 503A and 503B regulations to prepare customized medications tailored to individual patient needs. These pharmacies dispense medications directly to patients as prescribed by Henry Meds providers.
  • Quest DiagnosticscoreTechnology or IntegrationQuest Diagnostics provides laboratory testing services for Henry Meds patients, including at-home collection options via Quest facilities or through hybrid solutions like Tasso+ self-collection devices.
  • American Arbitration Association (AAA)minorOthersAAA administers arbitration proceedings for dispute resolution under the consumer arbitration rules and consumer due process protocol, as specified in the terms of service.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Henry Meds competitors and assessment

Company assessment

Direct peers

  • Ro: DTC telehealth company operating in weight management (including compounded GLP-1s through Ro Pharmacy), men's health, and women's health on a cash-pay subscription model. Direct overlap with Henry Meds' core verticals and pharmacy-fulfillment approach.
  • Noom Med: Subsidiary of Noom offering clinician-supervised GLP-1 weight management on a cash-pay monthly subscription. Directly overlaps with Henry Meds' GLP-1 weight management program and shares the cash-pay chronic-condition positioning.
  • LifeMD: Subscription-based telehealth platform offering weight management (including compounded semaglutide via subsidiary), men's hormone therapy, women's HRT, and ED treatment. Operates on a similar cash-pay subscription model with vertically integrated pharmacy.
  • BlueChew: DTC telehealth subscription service for oral erectile dysfunction medications (sildenafil/tadalafil) on a cash-pay monthly model. Directly comparable to Henry Meds' ED oral offering on price, channel, and customer profile.
  • Sesame: DTC telehealth marketplace offering weight loss (including GLP-1 programs), men's and women's health, and primary care on cash-pay pricing. Competes with Henry Meds on the cash-pay chronic-condition patient with similar self-pay positioning.
  • RedBox Rx: DTC telehealth platform offering ED, hair loss, and weight management on cash-pay subscription pricing. Directly comparable subscription model and cash-pay chronic-condition positioning to Henry Meds.
  • Hims & Hers Health: Publicly traded DTC telehealth platform offering weight loss (GLP-1s), men's health (TRT, ED), women's health (HRT), and hair/skin care on a subscription cash-pay model. Closest direct competitor to Henry Meds across all four product verticals with materially larger scale and brand reach.

Emerging players

  • PlushCare: Telehealth primary care and weight management platform offering GLP-1 treatment via insurance and cash-pay options. Adjacent competitor in Henry Meds' weight management vertical with broader primary care scope.
  • Alpha Hormones: Specialty telehealth clinic focused on testosterone replacement therapy, men's hormone optimization, and weight management with cash-pay subscription pricing. Directly overlaps with Henry Meds' TRT and weight management verticals, smaller scale.

Others

  • Quest Diagnostics: National clinical laboratory partner of Henry Meds providing lab testing services (including via Tasso at-home collection). Enabler in Henry Meds' HRT/TRT service delivery rather than a direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Henry Meds social profiles

Digital presence

Henry Meds compliance and trust

Trust signal

Compliance2 records

Henry Meds financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Henry Meds leadership team

Management profile

Number of profiles

Profiles1 record

Henry Meds funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Henry Meds M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Henry Meds

What does Henry Meds do?

Henry Meds is a direct-to-consumer telehealth platform that connects patients with licensed healthcare providers for personalized treatment of chronic conditions, including weight management (GLP-1 medications), hormone replacement therapy (women's HRT and men's TRT), and erectile dysfunction therapy. Prescribed compounded medications are fulfilled by licensed U.S. compounding pharmacies and shipped directly to patients' homes on a self-pay, all-inclusive monthly subscription basis without requiring insurance.

Is Henry Meds a public or private company?

Henry Meds is a private company. It is classified as venture growth investor backed and is currently operating.

When was Henry Meds founded?

Henry Meds was founded in 2022. It employs 101 to 250 people.

Where is Henry Meds based?

Henry Meds is headquartered in Dover, United States, in the North America region.

How does Henry Meds make money?

One revenue line is on record: subscription Plans.

Who are Henry Meds's main competitors?

Direct peers on record are Ro, Noom Med, LifeMD, BlueChew, Sesame, RedBox Rx and Hims & Hers Health. Emerging players are PlushCare and Alpha Hormones. Quest Diagnostics is listed as an others.

Does Henry Meds have an API?

No public API is recorded for Henry Meds.

What industry is Henry Meds in?

Henry Meds's product category is Telehealth Healthcare Services. Its primary akta.pro industry code is HLALAIAA, DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription), with a secondary code of HLALAAAA, Primary Care & General Medicine Virtual Care. Its NAICS code is 621111 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PolicylabBest Affordable Online HRT Providers for 2026 (Compare Options)This article is a consumer guide comparing seven online telehealth hormone replacement therapy providers (Winona, Henry Meds, Eden, IVIM Health, Hone Health, Midi Health, and Alloy) based on pricing, clinical oversight, services included, and accessibility for 2026. The guide evaluates each platform's cost structure, ranging from approximately $120 to $300 per month depending on services and treatment type, along with their approach to lab testing, clinician access, and medication delivery. The article notes that in 2026 the FDA updated labeling for several menopausal hormone therapy products to better reflect current evidence on risks and benefits.YahooHenry Meds Brings Hormone Replacement Therapies and Personalized Care to Patients Suffering with Menopause and Perimenopause SymptomsHenry Meds announced it will provide hormone replacement therapy for menopause and perimenopause symptoms, with providers meeting patients virtually. The company cites NAMS guidelines and notes the average age of menopause onset is 52. Patients can book appointments at henrymeds.com/hrt.Business Wire BlogHenry Meds Brings Hormone Replacement Therapies and Personalized Care to Patients Suffering with Menopause and Perimenopause SymptomsHenry Meds announced it will provide hormone replacement therapy for menopause and perimenopause symptoms, with providers meeting patients virtually. The company follows NAMS guidelines and cites average menopause onset at 52, with about 6,000 Americans reaching menopause daily.CNBCEli Lilly sues four telehealth sites selling compounded Zepbound, MounjaroEli Lilly sued four telehealth companies—Mochi Health, Fella Health, Willow Health, and Henry Meds—on Wednesday for selling compounded versions of its Zepbound and Mounjaro drugs. The company alleges they deceive consumers and turn them away from Lilly's medicines, seeking to stop the sales.Business Wire BlogHenry Meds Revolutionizes Weight Loss Treatment with Oral Tirzepatide Dissolvable TabletsHenry Meds launched compounded oral dissolving tirzepatide tablets, an oral format of the weight-loss drug. The telehealth platform offers the medication through licensed compounding pharmacies with no insurance needed. The tablets are not FDA-approved and require a prescription from a licensed provider.Santa Cruz SentinelHenry Meds Compounded Semaglutide Prescribed Online: What to KnowHenry Meds offers compounded semaglutide for weight loss via online prescription and telehealth. The drug is a GLP-1 agonist with weekly dosing, priced at $297 per month, and backed by over 1,000 user reviews and a 30-day refund policy.